BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28471663)

  • 1. Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2).
    Rowbottom MW; Bain G; Calderon I; Lasof T; Lonergan D; Lai A; Huang F; Darlington J; Prodanovich P; Santini AM; King CD; Goulet L; Shannon KE; Ma GL; Nguyen K; MacKenna DA; Evans JF; Hutchinson JH
    J Med Chem; 2017 May; 60(10):4403-4423. PubMed ID: 28471663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
    Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
    Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
    Findlay AD; Foot JS; Buson A; Deodhar M; Jarnicki AG; Hansbro PM; Liu G; Schilter H; Turner CI; Zhou W; Jarolimek W
    J Med Chem; 2019 Nov; 62(21):9874-9889. PubMed ID: 31580073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
    Schilter H; Findlay AD; Perryman L; Yow TT; Moses J; Zahoor A; Turner CI; Deodhar M; Foot JS; Zhou W; Greco A; Joshi A; Rayner B; Townsend S; Buson A; Jarolimek W
    J Cell Mol Med; 2019 Mar; 23(3):1759-1770. PubMed ID: 30536539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.
    Smithen DA; Leung LMH; Challinor M; Lawrence R; Tang H; Niculescu-Duvaz D; Pearce SP; Mcleary R; Lopes F; Aljarah M; Brown M; Johnson L; Thomson G; Marais R; Springer C
    J Med Chem; 2020 Mar; 63(5):2308-2324. PubMed ID: 31430136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of nuclear LOXL2 inhibition in fibroblasts and myofibroblasts in the fibrotic process of acute respiratory distress syndrome.
    Matsuo A; Tanida R; Yanagi S; Tsubouchi H; Miura A; Shigekusa T; Matsumoto N; Nakazato M
    Eur J Pharmacol; 2021 Feb; 892():173754. PubMed ID: 33248114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lysyl oxidase-like 2.
    Moon HJ; Finney J; Ronnebaum T; Mure M
    Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX.
    Hutchinson JH; Rowbottom MW; Lonergan D; Darlington J; Prodanovich P; King CD; Evans JF; Bain G
    ACS Med Chem Lett; 2017 Apr; 8(4):423-427. PubMed ID: 28435530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer.
    Chang J; Lucas MC; Leonte LE; Garcia-Montolio M; Singh LB; Findlay AD; Deodhar M; Foot JS; Jarolimek W; Timpson P; Erler JT; Cox TR
    Oncotarget; 2017 Apr; 8(16):26066-26078. PubMed ID: 28199967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin.
    Schmelzer CEH; Heinz A; Troilo H; Lockhart-Cairns MP; Jowitt TA; Marchand MF; Bidault L; Bignon M; Hedtke T; Barret A; McConnell JC; Sherratt MJ; Germain S; Hulmes DJS; Baldock C; Muller L
    FASEB J; 2019 Apr; 33(4):5468-5481. PubMed ID: 30676771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin.
    Kim YM; Kim EC; Kim Y
    Mol Biol Rep; 2011 Jan; 38(1):145-9. PubMed ID: 20306300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
    Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV
    Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy.
    Stangenberg S; Saad S; Schilter HC; Zaky A; Gill A; Pollock CA; Wong MG
    Sci Rep; 2018 Jun; 8(1):9423. PubMed ID: 29930330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis.
    Aumiller V; Strobel B; Romeike M; Schuler M; Stierstorfer BE; Kreuz S
    Sci Rep; 2017 Mar; 7(1):149. PubMed ID: 28273952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
    Okada K; Moon HJ; Finney J; Meier A; Mure M
    Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.
    Mižíková I; Palumbo F; Tábi T; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
    Physiol Genomics; 2017 Aug; 49(8):416-429. PubMed ID: 28698228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
    Wei Y; Kim TJ; Peng DH; Duan D; Gibbons DL; Yamauchi M; Jackson JR; Le Saux CJ; Calhoun C; Peters J; Derynck R; Backes BJ; Chapman HA
    J Clin Invest; 2017 Oct; 127(10):3675-3688. PubMed ID: 28872461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.
    Chen W; Yang A; Jia J; Popov YV; Schuppan D; You H
    Hepatology; 2020 Aug; 72(2):729-741. PubMed ID: 32176358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomeric States and Hydrodynamic Properties of Lysyl Oxidase-Like 2.
    Meier AA; Moon HJ; Toth R; Folta-Stogniew E; Kuczera K; Middaugh CR; Mure M
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.